ロード中...
Nonvitamin K antagonist oral anticoagulant activity: challenges in measurement and reversal
BACKGROUND: Four nonvitamin K antagonist oral anticoagulants (NOACs) are approved for the prevention of stroke in patients with nonvalvular atrial fibrillation and for the treatment of venous thromboembolism. These include the direct thrombin inhibitor dabigatran and the direct factor Xa inhibitors...
保存先:
| 出版年: | Crit Care |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5034528/ https://ncbi.nlm.nih.gov/pubmed/27659071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-016-1422-2 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|